Kolexia
Elias Dominique
Chirurgie générale
Gustave-Roussy
Villejuif, France
193 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du péritoine Tumeurs colorectales Carcinomes Métastase tumorale Tumeurs du foie Récidive tumorale locale Tumeurs du rectum Complications postopératoires Métastase lymphatique

Industries

Roche
3 collaboration(s)
Dernière en 2016
Novartis
2 collaboration(s)
Dernière en 2016
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

PACHA-01: Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases - A Randomized Phase II/III Trial
Essai Clinique (Gustave-Roussy)   17 août 2023
Mid-Term Audit of a National Peritoneal Surface Malignancy Program Implementation in a Low Middle Income Country: The Moroccan Experience.
Cancers   03 mars 2021
Macrodystrophia lipomatosa of the left hallux.
Clinical and experimental dermatology   22 janvier 2021
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
The Lancet. Oncology   18 janvier 2021
Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).
Annals of surgery   10 décembre 2020
586P Bidirectional chemotherapy for initially unresectable malignant peritoneal mesothelioma: Proof of concept of a new conversion strategy?
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
The Lancet. Oncology   24 juillet 2020
Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy.
Oncogene   20 avril 2020
Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy.
Oncogene   20 novembre 2019
Grand Prix 2015 de Chirurgie Cancérologique Lauréat
Youtube @ Académie Nationale de Chirurgie FRANCE   29 juin 2019